Spectracure AbOMXSTO: SPEC

Spectracure Reports Positive Results In Prostate Cancer Study

· Issued by Spectracure Ab

SpectraCure AB (publ) OMXSTO:SPEC:

  • REPORTS POSITIVE 12-MONTH RESULTS IN PROSTATE CANCER STUDY